Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000593037 | SCV000702469 | pathogenic | not provided | 2016-10-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000700865 | SCV000829640 | pathogenic | Cone-rod dystrophy 6; Leber congenital amaurosis 1 | 2018-04-06 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln855*) in the GUCY2D gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been reported to segregate with Leber congenital amaurosis in a family (PMID: 10636733). This variant is also known as c.2646C>T in the literature. Loss-of-function variants in GUCY2D are known to be pathogenic (PMID: 10951519, 11328726, 17964524). For these reasons, this variant has been classified as Pathogenic. |
Mendelics | RCV000989742 | SCV001140286 | pathogenic | Cone-rod dystrophy 6 | 2019-05-28 | criteria provided, single submitter | clinical testing |